Public Prosecutor v Yeo Moon Seng

CourtDistrict Court (Singapore)
JudgeSalina Bte Ishak
Judgment Date06 January 2015
Neutral Citation[2015] SGDC 1
Citation[2015] SGDC 1
Publication Date09 January 2015
Docket Number924519—2014, Magistrate’s Appeal No: 9001 - 2015 - 01
Plaintiff CounselDSP Mohd Shaharuddin Bin Abu
Defendant CounselMr Yeo Moon Seng, the Accused acting in person
District Judge Salina Bte Ishak: The Charge

The Accused, Mr Yeo Moon Seng, had pleaded guilty to DAC 924519 - 2014, a single repeat drug consumption charge under Section 8(b)(ii) Misuse of Drugs Act (Cap 185, 2008 Rev Ed) and punishable under Section 33A(2) of the said Act. This charge is commonly referred to as a “long-term second-tier” or an “LT-2” charge which attract the enhanced penalties under the Act if a person has a prior conviction for a “long-term first-tier” or “LT-1” charge.

Summary of Facts

The Statement of Facts (“Exhibit PS1”) which the Accused had agreed to without qualification reads as follows: The accused is Yeo Moon Seng, SXXXX160A, Male/57, DOB: 6 January 1957. On 27 October 2014 at about 11.30 am at Tanglin Police Divisional HQ, accused was arrested by CNB officers. A search was conducted but no drug exhibits was found.

Facts Pertaining to 1st Charge: Consumption of a Specified Drug – LT 2

At Tanglin Police Divisional HQ, the accused provided two bottles of his urine samples on 27 October 2014 which were sealed “CENTRAL NARCOTICS BUREAU” and marked “C-SE-14-00766-1 YEO MOON SENG SXXXX160A” and “C-SE-14-00766-2 YEO MOON SENG SXXXX160A” in his presence. The said urine samples were sent to the Health Sciences Authority (HSA) on 28 October 2014 for analysis. The HSA subsequently issued two Certificates under Section 16 of The Misuse of Drugs Act (CAP. 185) bearing Lab Nos: AT-1433-10194-001-01 and AT-1433-10194-002-01 on 31 October 2014 respectively. Quek Wee Kiat, an analyst with the Analytical Toxicology Laboratory of the HSA, having conduct of the analysis in relation to the urine sample marked as “C-SE-14-00766-1 YEO MOON SENG SXXXX160A” issued the Certificate bearing Lab No: AT-1433-10194-001-01, stating that on analysis, the said urine sample was found to contain Monoacetylmorphine. Tan Joo Chin, an analyst with the Analytical Toxicology Laboratory of the HSA, having conduct of the analysis in relation to the urine sample marked as “C-SE-14-00766-2 YEO MOON SENG SXXXX160A” issued the Certificate bearing Lab No: AT-1433-10194-002-01, stating that on analysis, the said urine sample was found to contain Monoacetylmorphine. Monoacetylmorphine is a Specified Drug listed in The Fourth Schedule to The Misuse of Drugs Act Chapter 185. Monoacetylmorphine is a known metabolite of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT